Spiracur’s SNaP Wound Care System Proving Itself in Trials

free biotech news

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Positive clinical benefits are continuing to be seen from the SNaP ultraportable negative pressure wound therapy (NPWT) system developed by Spiracur (Sunnyvale, Calif.-based company). NPWT is a therapeutic technique using a vacuum dressing to promote healing in acute or chronic wounds (such as diabetic foot ulcers, pressure ulcers and surgical incisions), that can also be used to optimize healing of first and second degree burns.The continued vacuum draws out fluid from the wound area and increases blood flow to the region. The SNaP System is the first FDA cleared non-powered, single use NPWT device. It provides the same level of negative pressure therapy as existing technologies but requires no electric or battery power and is 100% disposable.

Hey, check out all the engineering jobs. Post your resume today!

MORE ON THIS TOPIC